# Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

Study · id `cardio:ct-nct06122974` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06122974](<https://clinicaltrials.gov/study/NCT06122974>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06122974

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 518 participants.

## Technical summary

Registry record NCT06122974. Randomized; single masking; primary purpose treatment. Start 2026-08 (anticipated); primary completion 2032-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 518 participants (planned count; ClinicalTrials.gov record NCT06122974, source copy `cardio:ctgov-nct06122974-2026-01-07`, retrieved 2026-10-31)
- Planned start: 2026-08 (anticipated) (ClinicalTrials.gov record NCT06122974, source copy `cardio:ctgov-nct06122974-2026-01-07`, retrieved 2026-10-31)
- Primary completion: 2032-06 (anticipated) (ClinicalTrials.gov record NCT06122974, source copy `cardio:ctgov-nct06122974-2026-01-07`, retrieved 2026-10-31)
- Completion: 2037-12 (anticipated) (ClinicalTrials.gov record NCT06122974, source copy `cardio:ctgov-nct06122974-2026-01-07`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06122974-2026-01-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
- Acronym: DEEPER RCT
- Condition: Critical Limb Ischemia
- Intervention (Device): Drug Eluting Temporary Spur Stent System
- Intervention (Device): Percutaneous Transluminal Balloon Angioplasty
- Lead sponsor: ReFlow Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: ReFlow Medical, Inc. (`cardio:org-reflow-medical-inc`)

## Provenance

Content hash: e6fb810126542e00f66e146b9dc1631daf85a65d99abb7e2dca61a1bd8449ca4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
